In Brief
Ndufs4(KO) mice are very hypersensitive to volatile anesthetics. Zimin et al. show that VGLUT2-specific Ndufs4(KO) mice recapitulated the phenotype, while GABAergic and cholinergic Ndufs4(KO) did not. Isoflurane selectively inhibited excitatory neurotransmission in the CA1 of the hippocampus of Ndufs4(KO) at a dose that did not affect controls.
SUMMARY
An enigma of modern medicine has persisted for over 150 years. The mechanisms by which volatile anesthetics (VAs) produce their effects (loss of consciousness, analgesia, amnesia, and immobility) remain an unsolved mystery. Many attractive putative molecular targets have failed to produce a significant effect when genetically tested in whole-animal models [1] [2] [3] . However, mitochondrial defects increase VA sensitivity in diverse organisms from nematodes to humans [4] [5] [6] . Ndufs4 knockout (KO) mice lack a subunit of mitochondrial complex I and are strikingly hypersensitive to VAs yet resistant to the intravenous anesthetic ketamine [7] . The change in VA sensitivity is the largest reported for a mammal. Limiting NDUFS4 loss to a subset of glutamatergic neurons recapitulates the VA hypersensitivity of Ndufs4(KO) mice, while loss in GABAergic or cholinergic neurons does not. Baseline electrophysiologic function of CA1 pyramidal neurons does not differ between Ndufs4(KO) and control mice. Isoflurane concentrations that anesthetize only Ndufs4(KO) mice (0.6%) decreased the frequency of spontaneous excitatory postsynaptic currents (sEPSCs) only in Ndufs4(KO) CA1 neurons, while concentrations effective in control mice (1.2%) decreased sEPSC frequencies in both control and Ndufs4(KO) CA1 pyramidal cells. Spontaneous inhibitory postsynaptic currents (sIPSCs) were not differentially affected between genotypes. The effects of isoflurane were similar on evoked field excitatory postsynaptic potentials (fEPSPs) and paired pulse facilitation (PPF) in KO and control hippocampal slices. We propose that CA1 presynaptic excitatory neurotransmission is hypersensitive to isoflurane in Ndufs4(KO) mice due to the inhibition of pre-existing reduced complex I function, reaching a critical reduction that can no longer meet metabolic demands.
RESULTS AND DISCUSSION
Complex I Dysfunction in VGLUT2-Expressing Neurons Recapitulates Hypersensitivity to Isoflurane and Halothane Observed in the Total KO Mice To understand the cell specificity of mitochondrial complex I dysfunction and anesthetic hypersensitivity, we investigated the sensitivity to isoflurane and halothane of control mice compared with that of mice with Ndufs4 knocked out selectively in GABAergic neurons (GABA-specific knockout [KO] mice), VGLUT2-positive glutamatergic neurons (VGLUT2-specific KO mice), or cholinergic neurons (CHAT-specific KO mice). VGLUT2-specific KO mice were markedly hypersensitive to isoflurane and halothane, similar to the total KO mice. GABAspecific and CHAT-specific KO mice were not hypersensitive to either halothane or isoflurane, except for a small increase in sensitivity of CHAT-specific KO mice to halothane (Figure 1 ). These results support the hypothesis that excitatory glutamatergic transmission is the major contributor to volatile anesthetic (VA) hypersensitivity of KO mice.
Complex I Dysfunction Does Not Affect Intrinsic Membrane Properties and Synaptic Baseline Activity in Hippocampal CA1 Pyramidal Neurons To understand the link between mitochondrial complex I dysfunction and anesthetic hypersensitivity, we investigated intrinsic and synaptic properties of hippocampal CA1 pyramidal neurons in KO animals at baseline and following exposure to isoflurane. The CA1 region is a well-characterized region whose response to a multitude of anesthetics has been studied extensively and that also has been implicated in the function of VAs [8] [9] [10] [11] [12] . We found no significant differences in the intrinsic membrane properties of hippocampal CA1 pyramidal neurons in slices obtained from control and KO mice. The resting membrane potential was À61.03 ± 1.24 mV and À62.33 ± 1.05 mV for control and KO cells, respectively. Cellular input resistance was 152.39 ± 6.25 MU and 148.28 ± 5.58 MU for control and KO cells, respectively.
No differences were found in spontaneous excitatory postsynaptic current (sEPSC) frequency, amplitude, and decay time between genotypes (Figure 2A ). There were no significant differences between KO and control neurons in miniature excitatory postsynaptic current (mEPSC) frequency, amplitude, and decay time at baseline ( Figure 2B ).
There were no differences in spontaneous inhibitory postsynaptic current (sIPSC) frequency, amplitude, and decay time between KO and control neurons ( Figure 2C ). Finally, there were no differences in miniature inhibitory postsynaptic current (mIPSC) frequency, amplitude, and decay time between KO and control neurons ( Figure 2D ).
These results indicate that neuronal function in CA1 hippocampal pyramidal cells was not different between control and KO mice in the absence of anesthetic. Thus, hypersensitivity to isoflurane in KO mice is not due to a generalized metabolic deficiency in basic neuronal function. The specific resistance of the mutant to ketamine also supports the conclusion that a general metabolic deficiency is unlikely the explanation for the hypersensitivity to VAs [7] .
Our recordings were made before any symptoms or histopathologic changes developed in the mutant and from a region that was relatively spared from degeneration. The fact that most parameters studied failed to show differences between control and KO cells at baseline is consistent with the fact that ATP concentrations in muscle and blood are not decreased in the mutant [13] . In fact, the respiratory capacity of intact mitochondria in the KO is 50%-100% of the wild-type, depending on the complex I substrate [14] . Additional sources of ATP, such as glycolysis, also could compensate to some degree in order to maintain network activity at baseline.
CA1 sEPSC Frequency Is Hypersensitive to 0.6% Isoflurane in KO Neurons
We next studied the effects of mitochondrial dysfunction on synaptic activity with isoflurane exposure. Exposure to 0.6% isoflurane significantly decreased the sEPSC frequency of KO cells without changing the sEPSC frequency of control neurons (Figures 3A and 3B). Moreover, sEPSC frequency in KO neurons did not fully revert to pre-exposure levels after 15 min of wash with artificial cerebrospinal fluid (ACSF). Interestingly, sEPSC amplitudes and decay times were not affected by 0.6% isoflurane exposure in either control or KO neurons ( Figures 3C  and 3D ).
In the presence of 1.2% isoflurane, sEPSC frequency was significantly reduced in both KO and control neurons (Figures 3A and 3B). As was the case for 0.6% isoflurane, sEPSC frequency did not fully recover after 15 min of wash in KO cells, while sEPSC frequency of control neurons returned to the level prior to exposure ( Figure 3B ). To rule out a possible isoflurane-independent run-down, control experiments were performed in which KO cells were voltage clamped and sEPSC frequency was monitored for the duration of the isoflurane treatment experiment. No significant change in sEPSC frequency was observed (data not shown). Exposure to 1.2% isoflurane did not affect sEPSC amplitude or decay time in either control or KO cells (Figures 3C and 3D) . Application of 0.6% isoflurane did not cause any changes in mEPSC frequency, amplitude, or decay time in either genotype ( Figures 3E-3H ).
Isoflurane caused a specific inhibition of sEPSC frequency only in mutant cells at a dose that anesthetized mutant animals, but not controls. Control cells showed an identical response at a dose that approximated the EC 50 of isoflurane in vivo for control animals. This implies that the same phenomenon underlies the effect of isoflurane on synaptic transmission in both genotypes and determines the in vivo response.
Interestingly, sEPSC frequency in KO cells did not return to baseline following exposure to isoflurane. It is unlikely that isoflurane irreversibly binds to its target, since anesthetized KO mice awaken within 5-10 min after removal from 0.4% isoflurane. Additionally, membrane potential was maintained throughout cellular recordings, supporting the conclusion that While GABA-specific KO and CHAT-specific KO mice show similar EC 50 values for isoflurane (ISO) and halothane (HAL) to control mice, VGLUT2-specific KO mice demonstrate hypersensitivity to both anesthetics. Data for the total KO mice were published before [7] and are shown here for comparison. Anesthetic concentrations are expressed in percentage by volume. Graph bars represent mean and error bars represent SD. EC 50 values for ISO and HAL were reduced in VGLUT2-specific KO mice (p < 0.001 for both ISO and HAL; global control, n = 10 mice for ISO and n = 6 mice for HAL; global KO, n = 10 mice for ISO and n = 6 mice for HAL; VGLUT2-specific control, n = 5 mice for ISO and n = 7 mice for HAL; VGLUT2-specific KO, n = 5 mice for ISO and HAL). EC 50 values for ISO and HAL were not significantly different between GABA-specific KO mice and corresponding control mice (p = 0.176 for ISO and p = 0.585 for HAL; GABA-specific control, n = 6 mice for ISO and n = 5 mice for HAL; GABA-specific KO, n = 6 mice for ISO and HAL). While EC 50 values for ISO were not significantly different between CHAT-specific KO mice and their controls (p = 0.420; CHATspecific control, n = 6 mice; CHAT-specific KO, n = 5 mice), there was a small statistically significant difference in EC 50 values for HAL (p = 0.034; CHAT-specific control, n = 10 mice; CHAT-specific KO, n = 7 mice). See also Table S1. cell death is not the cause of irreversibility of isoflurane-induced sEPSC frequency decrease. Since isoflurane is non-detectable in the superfusion-recording chamber after 15 min of wash as measured by gas chromatography, our results could be explained by the inability of mitochondria to recover ATP levels within the experimental time frame. Additional studies are required to provide mechanistic insights into this phenomenon.
Studies of the effects of isoflurane on sEPSC parameters on slices from GABAergic-and cholinergic-specific KO mice did not show differences between mutant and control slices. Although frequencies decreased in both mutant and control lines, this change did not reach significance (Figure S1 ). Additional effectors may exist for synaptic responses to isoflurane. 
Isoflurane Increases CA1 sIPSC Decay Time Similarly in KO and Control Neurons
The sIPSC frequency was not affected by 0.6% isoflurane in either KO or control genotypes ( Figures S2A and S2B ). Exposure to 0.6% isoflurane slightly decreased sIPSC amplitude in control cells without an effect on sIPSC amplitude in KO cells (Figure S2C) . Application of 0.6% isoflurane increased sIPSC decay time similarly in control and KO neurons, which returned to preexposure levels after 15 min of wash with ACSF ( Figure S2D) . Application of 1.2% isoflurane did not affect sIPSC frequency and amplitude of either genotype tested ( Figures S2A-S2C ). Exposure to 1.2% isoflurane increased sIPSC decay time equally in control and KO neurons ( Figure S2D ), which returned to preexposure levels with 15 min of wash. The mIPSC frequency was not affected by 0.6% isoflurane exposure in either control or KO cells ( Figures S2E and S2F) . The mIPSC amplitude decreased slightly, but statistically significantly, following exposure to 0.6% isoflurane ( Figure S2G ). The mIPSC amplitude after wash was not significantly different from pre-exposure levels. The mIPSC decay time increased after 0.6% isoflurane exposure in both genotypes similarly, and it returned to pre-exposure level after wash ( Figure S2H ).
An anesthetic-induced increase in sIPSC decay time is consistent with previous reports [15] , interpreted to be a result of isoflurane interacting with GABA A receptors directly. Mitochondrial complex I dysfunction did not affect sIPSC parameters at baseline. The sIPSC amplitude demonstrated a small decrease after 0.6% isoflurane exposure in control, but not in KO, cells. Since mIPSC data did not show any differential effect after 0.6% isoflurane exposure, the differential effect of 0.6% isoflurane on sIPSC amplitude could be due to differences in GABAergic neuronal spiking. However, the magnitude of the effect makes it unlikely to be of biological significance. These results indicate that hippocampal inhibitory circuitry is not affected by mitochondrial complex I dysfunction and that the differential signaling in CA1 neurons between mutant and control cells is not the result of increased upstream inhibitory signaling. The lack of effect of NDUFS4 loss in GABAergic neurons on sensitivity to isoflurane and halothane as measured by tail clamp also supports this conclusion.
Isoflurane-Induced Depression of fEPSPs Is Larger in KO Slices Than in Control Slices
We next studied the effects of isoflurane on evoked field excitatory postsynaptic potentials (fEPSPs) and paired pulse facilitation (PPF) in KO and control hippocampal slices ( Figure 4A ). At baseline PPF ratios were similar for KO and control slices (Figures 4B-4D ). The PPF ratios were not significantly different at various inter-pulse intervals ranging from 10 to 100 ms between control and KO slices ( Figure S3) .
Application of 0.6% isoflurane increased the PPF ratio of both control and KO slices similarly (Figures 4B and 4F ). In addition, 0.6% isoflurane reversibly decreased the amplitudes of first and second fEPSPs similarly for control and KO slices ( Figures  4B and 4D) . Application of 1.2% isoflurane increased the PPF ratio of both control and KO slices similarly (Figures 4C and  4F ). In addition, 1.2% isoflurane depressed both first and second fEPSPs to a greater extent than 0.6% isoflurane, and it depressed fEPSPs in KO slices more than in control slices (Figures 4C-4E ).
An increase in PPF ratio concurrent with a depression of fEPSP amplitude after exposure to VAs has been reported [16, 17] , and it has been interpreted as evidence for presynaptic depression of calcium-dependent glutamate release. In this study, we observed a larger depression of fEPSP amplitude in KO neurons following the exposure to 1.2% isoflurane. This result, coupled with data in Figure 1 , further suggests that glutamatergic synapses are affected by the mitochondrial complex I dysfunction, probably due to their high energy demand upon stimulation. This finding is consistent with the study by Pathak et al. [18] that reported that electrical stimulation-induced depression of ATP concentration in synaptic boutons is larger in KO cells than in WT cells. The fiber volleys, a measure of a number of action potentials arriving to nerve terminals, were not affected by isoflurane at either concentration tested (data not shown). This result indicates that the fEPSP depression could not be explained by the attenuation of action potential conduction in KO slices.
Depression of first and second fEPSP amplitudes after isoflurane exposure appears to contradict whole-cell patch-clamp data, where we did not see any changes to sEPSC amplitudes. This finding could be explained by increased energy demand of nearly synchronous recruitment of a large number of fibers in extracellular recordings.
Conclusions
We have found that the VA hypersensitivity of KO mice is recapitulated when the gene is lost in the distribution of the Vglut2 promoter. Electrophysiologic studies reveal that the characteristics of the CA1 of the hippocampus are not changed in the mutant, except when exposed to isoflurane. A low concentration of isoflurane decreased the frequency of sEPSCs only in the mutant. Since mEPSCs of KO neurons were not affected by 0.6% isoflurane, it is possible that isoflurane reduced the network input into CA1 pyramidal cells, rather than synaptic transmission within the CA1 region. Our results with sIPSCs and with field potentials make this explanation unlikely. Isoflurane also has been demonstrated to inhibit vesicle exocytosis through reduced Ca 2+ influx specifically in excitatory synapses [19] . Ca 2+ influx could be differentially affected in KO neurons in response to isoflurane, thereby explaining specific inhibition of sEPSC frequency following 0.6% isoflurane exposure. Alternatively, KO excitatory synapses, when exposed to isoflurane, may lack the ability to meet the increased energy demands of spontaneous firing compared to the resting state of mEPSCs. It will, therefore, be useful to explore the electrophysiological effects of Ndufs4 mutation under states of high energy demand. There are several energy-demanding processes of neuronal signaling, including reversal of Na + entry for action potentials, reversal of Na + entry at resting potential, reversal of ion fluxes through postsynaptic receptors, glutamate recycling, and reversal of presynaptic Ca 2+ entry [20] . Since the fiber volley amplitude was not affected after 0.6% or 1.2% isoflurane exposure in KO slices, it is unlikely that inhibition of reversal of Na + entry for action potentials is the mechanism explaining hypersensitivity of KO animals to VAs. Inhibition of any remaining energy-demanding processes could explain the hypersensitivity of KO animals. Mitochondria are increasingly appreciated by a broad audience as key regulators of neuronal activity, yet their role in the state of anesthesia is not clear. It has long been known that VAs specifically inhibit complex I function in isolated mitochondria from worms and mammals [21, 22] . Our work in worms, mice, and children corroborated these in vitro findings implicating complex I, compared to other mitochondrial components, as uniquely controlling anesthetic sensitivity [6, 7, 23] . Taken together, these data link a very novel target of VAs to a specific facet of normal neuronal function, and they suggest that glutamatergic neurotransmission is selectively sensitive to isoflurane in the mutant. We hypothesize that VA inhibition of complex I in a mutant with compromised complex I function may deplete ATP levels such that presynaptic function is limited in the CA1 and perhaps elsewhere, as glutamatergic cells no longer match energy demand with supply. This same pathway could exist in animals with normal complex I function, but it could require higher concentrations of isoflurane to achieve limiting amounts of ATP.
Several questions remain. We cannot yet explain how our current data relate to the resistance of the animal to ketamine, although it is now clear that this drug has many possible targets [24] . Also, we have not ruled out that mitochondria may be a de novo target for VAs in the mutant, although the main electrophysiologic change we measured in isoflurane occurred at a dose that approximates the EC 50 of the drug for the whole-animal phenotype. We infer that the simplest model is that mitochondria are, in fact, a target of VAs and that inhibition of specific circuit elements, energy-dependent excitatory transmission, is a mechanism that underlies sensitivity to VAs in the KO.
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